Roche Begins Shipments For New Supplies Of Tamiflu In US

Roche has begun shipping additional quantities of oral suspension (liquid), Tamiflu (oseltamivir phosphate). The added supplies of Tamiflu will begin arriving in pharmacies nationwide and will continue to roll out to wholesale and retail pharmacies during the next several weeks.

Together, the formulations provide various dispensing options for treating children with influenza.

Tamiflu is available in 75mg capsules for adults, 30mg and 45mg (liquid)capsules for children or people who have difficulty swallowing capsules.

Roche continues to make all forms of Tamiflu, and increasing quantities of Tamiflu oral suspension will become available over the next several weeks through the beginning of next year.

Tamiflu attacks the flu virus at its source, preventing it from replicating in the body. Recommendations from the US Centers for Disease Control and Prevention (CDC) on use of antivirals, such as Tamiflu, in management of seasonal and pandemic H1N1 influenza are available.

Roche has invested to increase its global manufacturing capacity to meet Tamiflu demand during pandemic preparedness and response. The expanded global manufacturing network, which includes 19 partners in 10 countries on three continents, has enabled Roche to boost Tamiflu production 15-fold since 2004.